Search

Your search keyword '"Monif, Mastura"' showing total 356 results

Search Constraints

Start Over You searched for: Author "Monif, Mastura" Remove constraint Author: "Monif, Mastura"
356 results on '"Monif, Mastura"'

Search Results

5. CLADIN- CLADribine and INnate immune response in multiple sclerosis – A phase IV prospective study

9. Neutropaenia complications from Ocrelizumab and Rituximab treatment

20. The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study.

21. Electroclinical biomarkers of autoimmune encephalitis

25. Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic

27. Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)

29. Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.

31. Clinical outcomes among initial survivors of cryptogenic new‐onset refractory status epilepsy (NORSE)

32. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies

33. The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease

37. Repetitive mild traumatic brain injury elicits a reactive microglial morphology and elevates serum neurofilament light levels, independent of NLRP3 inflammasome inhibition

42. 2808 Exploring the uptake, and real-world efficacy of intramuscular tixagevimab150mg/150mg cilgavimab (EvusheldTM) in multiple sclerosis patients (pwMS) during COVID 19 pandemic

43. 8 Cervical abnormality risk increases in women with MS treated with high-efficacy disease modifying therapy

44. 7 CLADIN: CLADribine and INnate immune responses in multiple sclerosis

46. 2785 Executive dysfunction in patients with autoimmune encephalitis – a study of Australian autoimmune encephalitis consortium

47. 6 Spike antibody seroconversion and emerging variant cross-reactivity following COVID-19 third vaccination dose in Australian people with multiple Sclerosis

48. 2781 Memory outcomes in patients with autoimmune encephalitis – a study of the Australian autoimmune encephalitis consortium

Catalog

Books, media, physical & digital resources